Cargando…
Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation
BACKGROUND: Oral Factor Xa inhibitors for the prevention of stroke in atrial fibrillation require dose adjustment based on certain clinical criteria, but the off-label use of the reduced doses is common. METHODS: Data from an observational registry including patients admitted with acute cerebral isc...
Autores principales: | Stoll, Svenja, Macha, Kosmas, Marsch, Armin, Gerner, Stefan T., Siedler, Gabriela, Fröhlich, Kilian, Volbers, Bastian, Strasser, Erwin F., Schwab, Stefan, Kallmünzer, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320957/ https://www.ncbi.nlm.nih.gov/pubmed/32206901 http://dx.doi.org/10.1007/s00415-020-09795-3 |
Ejemplares similares
-
Acute Stroke With Large Vessel Occlusion and Minor Clinical Deficits: Prognostic Factors and Therapeutic Implications
por: Volbers, Bastian, et al.
Publicado: (2021) -
IV-Thrombolysis in Ischemic Stroke With Unknown Time of Onset—Safety and Outcomes in Posterior vs. Anterior Circulation Stroke
por: Macha, Kosmas, et al.
Publicado: (2021) -
The anesthetic approach for endovascular recanalization therapy depends on the lesion site in acute ischemic stroke
por: Fröhlich, Kilian, et al.
Publicado: (2021) -
Editorial: Pushing the boundaries in acute ischemic stroke treatment
por: Volbers, Bastian, et al.
Publicado: (2023) -
Cerebral lesions sites in neurosarcoidosis: a lesion mapping study
por: Fröhlich, Kilian, et al.
Publicado: (2023)